通过人工智能开发多参数预后评分以分层冠状动脉风险的重要性
本文论述了心血管风险分层对发病率与死亡率预测的关键作用,强调结合人工智能与多参数评分整合临床变量和心脏影像数据,可更全面准确评估患者风险并辅助临床决策。文章还指出需通过标准化计算机接口实现影像与临床数据交换,以推动多参数风险评分的广泛临床应用。
要点
- 结合人工智能的多参数冠状动脉风险评分有助于临床实践中的风险评估。
- 整合多种临床变量与心脏影像数据的预后评分能更全面准确评估个体风险。
- 广泛临床应用需借助能交换相关影像与临床数据的标准化计算机接口。
核心结论
- 整合人工智能的多参数冠状动脉风险评分可促进临床实践中的风险评估。
- 纳入多种临床变量和心脏影像数据的预后冠状动脉风险评分有必要且值得更多关注。
- 多参数风险评分的广泛临床应用应通过实施标准化计算机接口来实现。
研究设计与样本
- 本文为论述性文章,未报告系统检索范围或研究设计。
主要发现
- 多参数评分可跨不同临床场景提供更全面准确的患者个体风险评估。
- 此类评分支持临床医生基于综合评估做出更知情的决策。
- 人工智能革命日益依赖数字化人口学、临床和影像数据,正迅速使这些数据的可用性成为现实。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular risk stratification is crucial, as it is a key predictor of morbidity and mortality. The development of multiparametric scores for coronary risk stratification, integrated with artificial intelligence (AI), is important because it facilitates assessment in clinical practice. Therefore, prognostic coronary risk scores that incorporate multiple clinical variables and cardiac imaging data are necessary and deserve greater attention, as they provide a more comprehensive and accurate evaluation of individual patient risk across various clinical scenarios. Additionally, they support clinicians in making better-informed decisions based on a comprehensive assessment. Importantly, the widespread clinical use of multiparametric risk scores should be enabled by implementing standardized computer interfaces that can exchange the relevant imaging and clinical data needed to calculate these scores. The ongoing AI revolution, which increasingly relies on digital demographic, clinical, and imaging data, is rapidly making the availability of such data a reality.
引用
- Romero-Farina G, Aguadé-Bruix S, Cooke CD, et al. The importance of developing multiparametric prognostic scores to stratify coronary risk by means of artificial intelligence. Eur J Nucl Med Mol Imaging. 2025. PMID: 40879754. doi:10.1007/s00259-025-07510-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。